B. Riley Asset Management, LLC Harvard Bioscience Inc Transaction History

B. Riley Asset Management, LLC

$170 Million
Q3 2024

A detailed history of B. Riley Asset Management, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, B. Riley Asset Management, LLC holds 1,535,820 shares of HBIO stock, worth $3.23 Million. This represents 2.43% of its overall portfolio holdings.

Number of Shares

1,535,820

Previous 592,712 159.12%

Holding current value

$3.23 Million

Previous $1.59 Million 159.16%

% of portfolio

2.43%

Previous 1.72%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 04, 2024	BUY	$2.64 - $3.54 $2.49 Million - $3.34 Million	943,108 Added 159.12%	1,535,820 $4.13 Million
Q3 2024 Nov 14, 2024	SELL	$2.64 - $3.54 $2.49 Million - $3.34 Million	-943,108 Reduced 61.41%	592,712 $1.59 Million
Q2 2024 Aug 14, 2024	SELL	$2.77 - $4.63 $3.6 Million - $6.01 Million	-1,299,121 Reduced 45.83%	1,535,820 $4.38 Million
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $419,434 - $562,376	-104,337 Reduced 3.55%	2,834,941 $12 Million
Q4 2023 Feb 14, 2024	SELL	$4.0 - $5.49 $1.29 Million - $1.78 Million	-323,717 Reduced 9.92%	2,939,278 $15.7 Million
Q3 2023 Nov 14, 2023	BUY	$4.0 - $5.82 $800,128 - $1.16 Million	200,032 Added 6.53%	3,262,995 $14 Million
Q2 2023 Aug 14, 2023	SELL	$4.19 - $6.16 $1.45 Million - $2.13 Million	-345,833 Reduced 10.15%	3,062,963 $16.8 Million
Q1 2023 May 15, 2023	BUY	$2.45 - $4.22 $542,675 - $934,730	221,500 Added 6.95%	3,408,796 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$2.12 - $2.86 $3.12 Million - $4.21 Million	1,472,061 Added 85.82%	3,187,296 $8.83 Million
Q3 2022 Nov 14, 2022	BUY	$2.33 - $3.92 $397,470 - $668,704	170,588 Added 11.04%	1,715,235 $4.39 Million
Q2 2022 Aug 16, 2022	BUY	$3.28 - $6.42 $2.12 Million - $4.15 Million	646,211 Added 71.93%	1,544,647 $5.56 Million
Q1 2022 May 16, 2022	BUY	$5.16 - $7.14 $1.51 Million - $2.09 Million	292,042 Added 48.16%	898,436 $5.58 Million
Q4 2021 Feb 10, 2022	SELL	$6.37 - $8.18 $476,361 - $611,716	-74,782 Reduced 10.98%	606,394 $4.28 Million
Q4 2021 Feb 09, 2022	BUY	$6.37 - $8.18 $4.34 Million - $5.57 Million	681,176 New	681,176 $4.18 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $87.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Riley Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on B. Riley Asset Management, LLC with notifications on news.

Account

B. Riley Asset Management, LLC Harvard Bioscience Inc Transaction History